Close Menu

NEW YORK – Diagnostics companies got off to a strong start in 2021 as the stock prices of many firms rose during January and the 360Dx Index rose 10 percent month over month, continuing December's growth.

Of the 32 companies in the Index, 27 firms saw their share prices increase last month led by Fulgent Genetics (+112 percent), Genetron Health (+65 percent), Quidel (+40 percent), and Myriad Genetics (+39 percent). Meanwhile, five companies' stock prices fell slightly, led by Adaptive Biotechnologies (-6 percent) and GenMark Diagnostics (-5 percent).

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.